Mutagenesis by single site-specific arylamine-DNA adducts. Induction of mutations at multiple sites.
Two related carcinogen adducts, N-(deoxyguanosin-8-yl)-2-aminofluorene (AF) or N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene (AAF), were introduced into the lacZ' gene at base position 6253 of the minus strand of M13mp9 viral DNA. The construction of this site-specifically modified DNA was accomplished by first preparing a gapped heteroduplex missing 7 nucleotides at position 6251-6257 followed by ligation with an unmodified heptamer or with a heptamer containing either an AF or AAF adduct. These site-specifically modified templates were transfected into competent wild-type Escherichia coli cells (JM103) and a uvrA strain (SMH12). The mutation spectrum was determined by phenotypic selection of colorless plaques indicating a defective beta-galactosidase marker enzyme and by an in situ hybridization procedure to detect single base pair mismatches in the adduct region. DNA sequencing was used to characterize 179 of the mutants obtained. We found that both adducts were capable of inducing base substitution mutations at the adduct site and in the local region of the adduct. A specific frameshift (+1G) was also observed at a displaced site. All of the frameshift mutations occurred at the ligation site of the modified oligonucleotide. Control experiments with an unmodified oligonucleotide did not show an enhancement of mutations at this site, indicating that the adducts may have been responsible for these frameshifts. The mutations spectra induced by these adducts suggest that mutagenesis depends not only on adduct structure but also the sequence in which the adduct is located and the host cell type used for mutation expression.
Gupta
P K
PK
Department of Chemical Carcinogenesis, Michigan Cancer Foundation, Detroit, Michigan 48201.
Johnson
D L
DL
Reid
T M
TM
Lee
M S
MS
Romano
L J
LJ
King
C M
CM
D015073:2-Acetylaminofluorene / Q000031:analogs & derivatives* / Q000494:pharmacology; D001483:Base Sequence; D003090:Coliphages / Q000187:drug effects / Q000235:genetics*; D004279:DNA, Viral / Q000187:drug effects / Q000235:genetics*; D003849:Deoxyguanosine / Q000494:pharmacology / Q000031:analogs & derivatives; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics*; D005449:Fluorenes / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009153:Mutagens / Q000494:pharmacology*; D009154:Mutation; D010641:Phenotype; D015183:Restriction Mapping; D013014:SOS Response, Genetics; D014162:Transfection
D004279:DNA, Viral; D005449:Fluorenes; D009153:Mutagens; C031838:N-(deoxyguanosin-8-yl)-2-aminofluorene; C018776:N-(deoxyguanosin-8-yl)acetylaminofluorene; D015073:2-Acetylaminofluorene; D003849:Deoxyguanosine